Danaher Diagnostics — Operating Income (Loss) increased by 7.2% to $713.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 14.3%, from $624.00M to $713.00M. Over 2 years (FY 2023 to FY 2025), Diagnostics — Operating Income (Loss) shows an upward trend with a 4.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher operating income indicates strong operational efficiency and pricing power.
The profit earned from the diagnostics segment's core business operations after deducting operating expenses. It exclude...
The standard measure of segment performance across all industries.
dhr_segment_diagnostics_operating_income_loss| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $649.00M | $145.00M | $886.00M | $800.00M | $761.00M | $677.00M | $424.00M | $539.00M | $766.00M | $830.00M | $556.00M | $615.00M | $624.00M | $718.00M | $554.00M | $665.00M | $713.00M |
| QoQ Change | — | -77.7% | +511.0% | -9.7% | -4.9% | -11.0% | -37.4% | +27.1% | +42.1% | +8.4% | -33.0% | +10.6% | +1.5% | +15.1% | -22.8% | +20.0% | +7.2% |
| YoY Change | — | — | — | +23.3% | +424.8% | -23.6% | -47.0% | -29.2% | — | +22.6% | +31.1% | +14.1% | -18.5% | -13.5% | -0.4% | +8.1% | +14.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.